We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

2 hedge funds and large institutions have $17.6M invested in Seelos Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

396% more capital invested

Capital invested by funds: $3.56M → $17.6M (+$14.1M)

19% more call options, than puts

Call options by funds: $203K | Put options by funds: $170K

0% more funds holding

Funds holding: 2 → 2 (0)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
–
Increased
1
Reduced
–
Closed
–
Calls
$203K
Puts
$170K
Net Calls
+$33K
Net Calls Change
+$94K

Top Buyers

Rank Fund Capital Flow
1
SCM
Sarissa Capital Management
Connecticut
+$10.3M

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$112K
2
SIM
Spark Investment Management
New York
-$74K
3
Renaissance Technologies
Renaissance Technologies
New York
-$54K
4
RG
Rathbones Group
United Kingdom
-$25K
5
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$18K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
26
Tower Research Capital (TRC)
New York
$9K – – –
UBS Group
27
UBS Group
Switzerland
$6K – – –
Wells Fargo
28
Wells Fargo
California
$3K – – –
Citigroup
29
Citigroup
New York
$2K – – –
HDIM
30
Hanson & Doremus Investment Management
Vermont
$2K – – –
ST
31
Sphinx Trading
Illinois
$2K – – –
HI
32
Hudock Inc
Pennsylvania
$1K – – –
LTFS
33
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Simplex Trading
34
Simplex Trading
Illinois
$1K – – –
Manulife (Manufacturers Life Insurance)
35
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$8 – – –
Hudson Bay Capital Management
36
Hudson Bay Capital Management
Connecticut
– -$18K – –
NPC
37
National Planning Corporation
California
– -$7.07K – –
RG
38
Rathbones Group
United Kingdom
– -$25K – –
RC
39
RegentAtlantic Capital
New Jersey
– -$1.33K – –
Renaissance Technologies
40
Renaissance Technologies
New York
– -$54K – –
SIM
41
Spark Investment Management
New York
– -$74K – –
VKH
42
Virtu KCG Holdings
New York
– -$112K – –
1
2

SEEL Hedge Fund Activity: Q1 2015 in Review

2 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q1 2015, worth a combined $17.6M — up 396% from $3.56M a quarter earlier.

Fund positioning in SEEL was balanced in Q1 2015: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Sarissa Capital Management, adding an estimated $10.3M. The largest seller was Virtu KCG Holdings, cutting an estimated $112K.

  • 2 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q1 2015, unchanged from Q4 2014.
  • Funds reported $17.6M of Seelos Therapeutics, Inc. Common Stock stock for Q1 2015, up 396% quarter-over-quarter.
  • 0 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q1 2015 and 0 closed out.
  • The largest Seelos Therapeutics, Inc. Common Stock buyer in Q1 2015 was Sarissa Capital Management, an estimated $10.3M added.
  • The largest Seelos Therapeutics, Inc. Common Stock seller in Q1 2015 was Virtu KCG Holdings, an estimated $112K sold.

Based on aggregated 13F filings for Q1 2015.